Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nutex Health (NUTX) EBT Margin (2017 - 2025)

Nutex Health's EBT Margin history spans 16 years, with the latest figure at 17.07% for Q4 2025.

  • For Q4 2025, EBT Margin fell 2510.0% year-over-year to 17.07%; the TTM value through Dec 2025 reached 27.97%, up 508.0%, while the annual FY2025 figure was 27.97%, 508.0% up from the prior year.
  • EBT Margin for Q4 2025 was 17.07% at Nutex Health, down from 49.44% in the prior quarter.
  • Across five years, EBT Margin topped out at 1659.47% in Q1 2022 and bottomed at 1519.46% in Q3 2022.
  • The 5-year median for EBT Margin is 1.75% (2024), against an average of 1.65%.
  • The largest annual shift saw EBT Margin surged 188208bps in 2022 before it crashed -167338bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 4.19% in 2021, then crashed by -493bps to 16.48% in 2022, then plummeted by -167bps to 44.08% in 2023, then skyrocketed by 196bps to 42.18% in 2024, then crashed by -60bps to 17.07% in 2025.
  • Per Business Quant, the three most recent readings for NUTX's EBT Margin are 17.07% (Q4 2025), 49.44% (Q3 2025), and 9.73% (Q2 2025).